Vaccine News and Research

Latest Vaccine News and Research

Mysterious ailment, mysterious relief: Vaccines help some Covid long haulers

An estimated 10% to 30% of people who get Covid-19 suffer from lingering symptoms of the disease, or what’s known as “long Covid.”

16 Apr 2021

Pandemic highlights need for urgent care clinics for women

Last spring, only weeks into the pandemic, Christina Garcia was spending her days struggling to help her two young sons adjust to online schooling when she got such a heavy, painful period she could barely stand. After a few days, her vision began to blur and she found herself too weak to open a jar.

16 Apr 2021

Elderly patients of female physicians are more likely to be vaccinated against the flu

New UCLA research suggests that elderly patients of female physicians are more likely than those of male physicians in the same outpatient practice to be vaccinated against the flu.

16 Apr 2021

Rapid mRNA vaccination effectively controls SARS-CoV-2 transmission in long-term care facilities

Vaccine rollouts all over the world are aimed at cutting short the coronavirus disease 2019 (COVID-19) pandemic by inducing antibody-mediated immunity to the virus. A new study, recently released on the medRxiv* preprint server, addresses the successful reduction in viral spread and case incidence among residents of long-term care facilities (LTCF).

16 Apr 2021

COVID-19 vaccination of lactating mothers elicits specific IgA antibodies in breast milk

A new study, released on the medRxiv* preprint server, examines the presence of SARS-CoV-2-specific IgA in human milk and its association with the protection of breastfed infants against the disease.

16 Apr 2021

Curcumin nanosystems could be powerful COVID-19 therapeutics

With new variants of SARS-CoV-2 emerging, the COVID-19 pandemic is far from over. While the global vaccine rollout has moved at an impressive speed, the search for new safe, effective, and targeted therapies is still on. Now, a new study reviews the potential for curcumin, a natural alkaloid derived from turmeric, and nanosystems to treat COVID-19.

16 Apr 2021

Plans to hold Tokyo Olympic and Paralympic games must be reconsidered, argue experts

As the countdown to the Tokyo Olympic and Paralympic games reaches 100 days, plans to hold the games this summer must be reconsidered as a matter of urgency, argue experts in The BMJ today.

16 Apr 2021

Bristol-based new biotech company is developing ground-breaking treatments for Covid-19

A team of top scientists from the University of Bristol have announced the formation of a new biotech company that is developing ground-breaking and newly patented potential treatments for Coronavirus.

16 Apr 2021

Recovered COVID-19 patients may need only a single vaccine dose, suggests study

People who have recovered from COVID-19 had a robust antibody response after the first mRNA vaccine dose, but little immune benefit after the second dose, according to new research from the Penn Institute of Immunology. The findings, published today in Science Immunology, suggest only a single vaccine dose may be needed to produce a sufficient antibody response.

16 Apr 2021

Child vaccination rates decreased dramatically during COVID-19 pandemic, shows study

The numbers of recommended vaccine doses, including measles vaccine, administered to children decreased dramatically after the declaration of a national state of emergency on March 13, 2020, due to the COVID-19 pandemic, according to a Kaiser Permanente study published in Pediatrics.

16 Apr 2021

Analysis: Hispanic, Black, and Native Americans have carried the burden of COVID-19 pandemic

A UCLA Fielding School of Public Health-led team has found that Hispanic, Black, and Native Americans have carried the burden of the pandemic, both in overall mortality and specifically in years of potential life lost, in an analysis of 45 U.S. states and the District of Columbia (D.C.).

16 Apr 2021

More SARS-CoV-2 variants have emerged from immunocompromised hosts, shows research

A number of SARS-CoV-2 variants have emerged from immunocompromised hosts, research has identified. It is thought that variants of concern - including B.1.1.7, a variant first identified in Kent - were a result of long-term infection in people with a weakened immune system.

16 Apr 2021

Single dose of Oxford–AstraZeneca COVID vaccine shown to be more immunogenic than natural infection

By investigating antibody and T cell responses to a single dose of the Oxford–AstraZeneca COVID-19 vaccine, researchers from Sri Lanka and the United Kingdom have found that more than 90% of vaccinated individuals produced an adequate amount of antibodies after receiving only one dose of the vaccine – irrespective of their age and gender.

16 Apr 2021

Study: Previous COVID-19 infection does not completely protect against reinfection in young people

A past COVID-19 infection does not completely protect against reinfection in young people, according to an observational study of more than 3,000 healthy members of the US Marines Corps most of whom were aged 18-20 years, published in The Lancet Respiratory Medicine journal.

16 Apr 2021

Trial results show leishmaniasis vaccine is safe and induces immune responses in patients

The results of the first clinical trial of a new vaccine for a neglected tropical disease have demonstrated that it is safe and induces immune responses in patients with the infection.

15 Apr 2021

COVID-19 vaccine INO-4800 shows efficacy against SARS-CoV-2 variants

Researchers in the United States have demonstrated the efficacy of the vaccine INO-4800 against variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

15 Apr 2021

Chile and Uruguay are experiencing their worst moment of COVID-19 pandemic

Chile and Uruguay emerged as model cases last year for their handling of the COVID-19 crisis and are among the top five countriesin the world with the most vaccine doses administered per 100 people daily.

15 Apr 2021

UGA receives NIH contract to establish the Center for Influenza Disease and Emergence Research

The National Institutes of Health has awarded the University of Georgia a contract to establish the Center for Influenza Disease and Emergence Research.

15 Apr 2021

CUNY SPH announces the New York State Vaccine Education and Adoption Project

In a race to transform the vaccine-hesitant into adopters in New York City and surrounding counties as Covid-19 variants rise, the CUNY Graduate School of Public Health and Health Policy has announced the New York State Vaccine Education and Adoption Project.

15 Apr 2021

Can biomaterials offer novel therapeutic strategies against COVID-19?

A team of scientists reviews the current and potential impact of the biomaterial sciences on the COVID-19 pandemic.

15 Apr 2021

Vaccine News and Research

Latest Vaccine News and Research

Mysterious ailment, mysterious relief: Vaccines help some Covid long haulers

Pandemic highlights need for urgent care clinics for women

Elderly patients of female physicians are more likely to be vaccinated against the flu

Rapid mRNA vaccination effectively controls SARS-CoV-2 transmission in long-term care facilities

COVID-19 vaccination of lactating mothers elicits specific IgA antibodies in breast milk

Curcumin nanosystems could be powerful COVID-19 therapeutics

Plans to hold Tokyo Olympic and Paralympic games must be reconsidered, argue experts

Bristol-based new biotech company is developing ground-breaking treatments for Covid-19

Recovered COVID-19 patients may need only a single vaccine dose, suggests study

Child vaccination rates decreased dramatically during COVID-19 pandemic, shows study

Analysis: Hispanic, Black, and Native Americans have carried the burden of COVID-19 pandemic

More SARS-CoV-2 variants have emerged from immunocompromised hosts, shows research

Single dose of Oxford–AstraZeneca COVID vaccine shown to be more immunogenic than natural infection

Study: Previous COVID-19 infection does not completely protect against reinfection in young people

Trial results show leishmaniasis vaccine is safe and induces immune responses in patients

COVID-19 vaccine INO-4800 shows efficacy against SARS-CoV-2 variants

Chile and Uruguay are experiencing their worst moment of COVID-19 pandemic

UGA receives NIH contract to establish the Center for Influenza Disease and Emergence Research

CUNY SPH announces the New York State Vaccine Education and Adoption Project

Can biomaterials offer novel therapeutic strategies against COVID-19?

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Vaccine News and Research

Latest Vaccine News and Research

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in